Weiqing Jing

1.1k total citations
29 papers, 825 citations indexed

About

Weiqing Jing is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Weiqing Jing has authored 29 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 13 papers in Oncology and 10 papers in Hematology. Recurrent topics in Weiqing Jing's work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (8 papers) and Neuroblastoma Research and Treatments (8 papers). Weiqing Jing is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (8 papers) and Neuroblastoma Research and Treatments (8 papers). Weiqing Jing collaborates with scholars based in United States, China and Switzerland. Weiqing Jing's co-authors include Bryon D. Johnson, Jill A. Gershan, William Hallett, William R. Drobyski, Rimas J. Orentas, Katie Palen, Matthew J. Riese, Michael B. Dwinell, James J. Weber and Laura McOlash and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Weiqing Jing

29 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiqing Jing United States 15 479 452 248 225 90 29 825
Mobin Karimi United States 11 524 1.1× 414 0.9× 198 0.8× 291 1.3× 16 0.2× 32 927
I G Schmidt-Wolf Germany 13 636 1.3× 653 1.4× 96 0.4× 190 0.8× 36 0.4× 24 1.0k
Elizabeth Taras United States 11 338 0.7× 269 0.6× 135 0.5× 132 0.6× 14 0.2× 15 539
Leah J. Hogdal United States 12 203 0.4× 236 0.5× 285 1.1× 412 1.8× 17 0.2× 20 831
Dmitry Pankov United States 11 344 0.7× 464 1.0× 59 0.2× 183 0.8× 22 0.2× 17 620
Deanna A. Mele United States 8 187 0.4× 277 0.6× 393 1.6× 1.0k 4.6× 30 0.3× 14 1.2k
NK Cheung United States 9 229 0.5× 168 0.4× 172 0.7× 200 0.9× 157 1.7× 13 597
Massimiliano Petrini Italy 16 356 0.7× 294 0.7× 57 0.2× 291 1.3× 17 0.2× 41 619
Jiaxiong Tan China 16 447 0.9× 443 1.0× 158 0.6× 185 0.8× 12 0.1× 37 742
Cecilia Muñoz‐Calleja Spain 15 307 0.6× 286 0.6× 111 0.4× 199 0.9× 15 0.2× 41 696

Countries citing papers authored by Weiqing Jing

Since Specialization
Citations

This map shows the geographic impact of Weiqing Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqing Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqing Jing more than expected).

Fields of papers citing papers by Weiqing Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqing Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqing Jing. The network helps show where Weiqing Jing may publish in the future.

Co-authorship network of co-authors of Weiqing Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqing Jing. A scholar is included among the top collaborators of Weiqing Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqing Jing. Weiqing Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yingyu, Jing Li, Jocelyn A. Schroeder, Weiqing Jing, & Qizhen Shi. (2024). Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitors. Journal of Thrombosis and Haemostasis. 22(11). 3035–3047. 1 indexed citations
2.
Jing, Weiqing, Christina K. Baumgartner, Feng Xue, Jocelyn A. Schroeder, & Qizhen Shi. (2023). Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cells. Journal of Thrombosis and Haemostasis. 21(3). 488–498. 3 indexed citations
3.
Schroeder, Jocelyn A., Weiqing Jing, Calvin B. Williams, et al.. (2022). Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis. Frontiers in Immunology. 13. 1029356–1029356. 3 indexed citations
4.
Schroeder, Jocelyn A., Juan Fang, Weiqing Jing, et al.. (2021). Thromboelastometry assessment of hemostatic properties in various murine models with coagulopathy and the effect of factor VIII therapeutics. Journal of Thrombosis and Haemostasis. 19(10). 2417–2427. 6 indexed citations
5.
Jing, Weiqing, Donna McAllister, Katie Palen, et al.. (2019). STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models. Journal for ImmunoTherapy of Cancer. 7(1). 115–115. 153 indexed citations
6.
Jing, Weiqing, Juan Chen, Yingyu Chen, et al.. (2019). Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice. Blood Advances. 3(20). 3099–3110. 24 indexed citations
7.
Jing, Weiqing, Juan Chen, Yingyu Chen, et al.. (2019). Induction of Activated T Follicular Helper Cells Is Critical for Anti-FVIII Inhibitor Development in Hemophilia a Mice. Blood. 134(Supplement_1). 92–92. 1 indexed citations
8.
Jing, Weiqing, et al.. (2019). [Analysis of prognostic factors for hyperamylasemia following pancreaticoduodenectomy].. PubMed. 57(7). 534–539. 3 indexed citations
9.
Jing, Weiqing, Jill A. Gershan, Sandra Holzhauer, et al.. (2017). T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia. Cancer Research. 77(20). 5676–5686. 17 indexed citations
10.
Jing, Weiqing, Jill A. Gershan, Grace C. Blitzer, et al.. (2017). Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice. Journal for ImmunoTherapy of Cancer. 5(1). 51–51. 29 indexed citations
11.
Jing, Weiqing, Jill A. Gershan, James J. Weber, et al.. (2015). Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma. Journal for ImmunoTherapy of Cancer. 3(1). 2–2. 98 indexed citations
12.
Gershan, Jill A., et al.. (2015). Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma. Journal for ImmunoTherapy of Cancer. 3(1). 24–24. 9 indexed citations
14.
Jing, Weiqing, et al.. (2012). Examining T Cells at Vaccine Sites of Tumor-bearing Hosts Provides Insights to Dysfunctional T-Cell Immunity. Journal of Immunotherapy. 36(1). 41–51. 2 indexed citations
15.
Jing, Weiqing, Xiaocai Yan, William Hallett, Jill A. Gershan, & Bryon D. Johnson. (2011). Depletion of CD25+ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma. Blood. 117(25). 6952–6962. 34 indexed citations
16.
Hallett, William, Weiqing Jing, William R. Drobyski, & Bryon D. Johnson. (2011). Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade. Biology of Blood and Marrow Transplantation. 17(8). 1133–1145. 134 indexed citations
17.
Zheng, Jin, Weiqing Jing, & Rimas J. Orentas. (2009). Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade. Acta Biochimica et Biophysica Sinica. 41(12). 980–990. 17 indexed citations
18.
Johnson, Bryon D., Weiqing Jing, & Rimas J. Orentas. (2007). CD25+ Regulatory T Cell Inhibition Enhances Vaccine-induced Immunity to Neuroblastoma. Journal of Immunotherapy. 30(2). 203–214. 50 indexed citations
19.
Jing, Weiqing, Rimas J. Orentas, & Bryon D. Johnson. (2007). Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine. Biology of Blood and Marrow Transplantation. 13(3). 277–292. 17 indexed citations
20.
Paschen, Annette, Weiqing Jing, Ingo Drexler, et al.. (2005). Melanoma patients respond to a new HLA‐A*01‐presented antigenic ligand derived from a multi‐epitope region of melanoma antigen TRP‐2. International Journal of Cancer. 116(6). 944–948. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026